- Home
- TRST vs ORIC Comparison
TRST vs ORIC Comparison
Compare TRST & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- ORIC
- Stock Information
- Founded
- TRST 1902
- ORIC 2014
- Country
- TRST United States
- ORIC United States
- Employees
- TRST N/A
- ORIC N/A
- Industry
- TRST Major Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- TRST Finance
- ORIC Health Care
- Exchange
- TRST Nasdaq
- ORIC Nasdaq
- Market Cap
- TRST 612.5M
- ORIC 633.7M
- IPO Year
- TRST N/A
- ORIC 2020
- Fundamental
- Price
- TRST $32.51
- ORIC $10.00
- Analyst Decision
- TRST
- ORIC Strong Buy
- Analyst Count
- TRST 0
- ORIC 9
- Target Price
- TRST N/A
- ORIC $18.75
- AVG Volume (30 Days)
- TRST 117.3K
- ORIC 585.0K
- Earning Date
- TRST 01-21-2025
- ORIC 03-10-2025
- Dividend Yield
- TRST 4.42%
- ORIC N/A
- EPS Growth
- TRST N/A
- ORIC N/A
- EPS
- TRST 2.48
- ORIC N/A
- Revenue
- TRST $168,593,000.00
- ORIC N/A
- Revenue This Year
- TRST N/A
- ORIC N/A
- Revenue Next Year
- TRST $11.69
- ORIC N/A
- P/E Ratio
- TRST $12.99
- ORIC N/A
- Revenue Growth
- TRST N/A
- ORIC N/A
- 52 Week Low
- TRST $25.83
- ORIC $6.33
- 52 Week High
- TRST $38.89
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- TRST 43.85
- ORIC 57.64
- Support Level
- TRST $30.15
- ORIC $7.86
- Resistance Level
- TRST $32.94
- ORIC $11.15
- Average True Range (ATR)
- TRST 0.85
- ORIC 0.75
- MACD
- TRST 0.10
- ORIC 0.22
- Stochastic Oscillator
- TRST 61.46
- ORIC 65.05
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The Company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey and Vermont.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.